HealthcareBiotech & Life SciencesAIEnterprise SoftwareHardware & SemiconductorsSocial & CommunityConsumer
Northern Light Venture Capital (NLVC), founded in 2005, is a Chinese venture capital firm that primarily focuses on early-stage technology investments. The firm's strategy involves investing at the intersection of enterprise, healthcare, and consumer opportunities, as well as in TMT (technology, media, and telecom) and advanced technology sectors like AI and IoT, with a significant emphasis on Series A funding rounds.
They made 3 investments in the last 12 months. Their most common stage is series-a (57% of deals). Average disclosed round size is $61.2M (across 6 rounds with reported amounts).
Portfolio
7
Fund Size
$4.5B
Top Stage
Series A
Last 12 Mo
3
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
7 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Spiro Medical, Inc. | Series A | $67M | Jan 2026 |
| IiRegene Therapeutics | Series B | $40M | Sep 2025 |
| VVOC.AI | Series A | $15M | Apr 2025 |
| SStellar Cyber | Series A | $13.2M | Feb 2019 |
| BBlack Sesame International Holding | Series D | $218M | — |
| KKaixin001 | Seed | — | — |
 Chukong | Series A | $14M | — |
Top Co-Investors
Xiaomi1 shared
Tencent Investment1 shared
SK Group1 shared
Andera Partners1 shared
Omega Funds1 shared
Sherpa Healthcare Partners1 shared
HSG1 shared
Supernova Invest1 shared
Sequoia China1 shared
New Valley Ventures1 shared
Last updated: 6 March 2026